Successful high-dose methotrexate chemotherapy in a patient with acute lymphocytic leukemia who developed acute renal failure during the initial treatment

Pediatrics International

Volumn 49, Issue 6, 2007, Pages 1018-1019

  Isoda, Takeshi ^a   Ito, Sukeyuki ^a   Kajiwara, Michiko ^a   Nagasawa, Masayuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Acute lymphocytic leukemia; High dose methotrexate; Renal failure

Indexed keywords

CREATININE; FOLINIC ACID; METHOTREXATE;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOCYTIC LEUKEMIA; ALKALINIZATION; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CASE REPORT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; HUMAN; HYDRATION; INFANT; KIDNEY FUNCTION; NEPHROTOXICITY; PRIORITY JOURNAL; URINE PH; URINE VOLUME;

ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; HUMANS; INFANT; KIDNEY FAILURE, ACUTE; METHOTREXATE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 36649014934     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02461.x     Document Type: Article

References (10)

1. Bleyer WA. Clinical pharmacology: Guidelines for the clinical use of methotrexate. In : Hall RR (ed A Comprehensive Guide to the Therapeutic Use of Methotrexate in Bladder Cancer, 1st edn. Pharma Libri, Chicago, 1983 51 69.
2. Tsuchida M, Ikuta K, Hanada R et al. Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981-1995. Leukemia 2000 12 : 2295 306.
3. Adan L, Souberbielle JC, Blanche S et al. Adult height after cranial irradiation with 24 Gy: Factors and markers of height loss. Acta Paediatr. 1996 85 : 1096 101.
4. Groot-Loonen JJ, van Setten P, Otten BJ et al. Shortened and diminished pubertal growth in boys and girls treated for acute lymphoblastic leukaemia. Acta Paediatr. 1996 85 : 1091 5.
5. Moe PJ, Holen A. High-dose methotrexate in childhood all. Pediatr. Hematol. Oncol. 2000 17 : 615 22.
6. Strojan P, Popovic M, Jereb B. Secondary intracranial meningiomas after high-dose cranial irradiation: Report of five cases and review of the literature. Int. J. Radiat. Oncol. Biol. Phys. 2000 48 : 65 73.
7. Schatz J, Kramer JH, Ablin A, Matthay KK. Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 2000 14 : 189 200.
8. Abelson HT, Fosburg MT, Beardsley GP et al. Methotrexate-induced renal impairment: Clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J. Clin. Oncol. 1983 1 : 208 16.
9. Donelli MG, Zucchetti M, Robatto A et al. Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia. Med. Pediatr. Oncol. 1995 24 : 154 9.
10. Relling MV, Fairclough D, Ayers D et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J. Clin. Oncol. 1994 12 : 1667 72.